Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence - PubMed (original) (raw)
. 1995 Jun 16;270(24):14255-8.
doi: 10.1074/jbc.270.24.14255.
Affiliations
- PMID: 7782278
- DOI: 10.1074/jbc.270.24.14255
Free article
Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
Y Z Lin et al. J Biol Chem. 1995.
Free article
Abstract
To control agonist-induced nuclear translocation of transcription factor kappa B (NF-kappa B) in intact cells, cell-permeable synthetic peptides were devised. Their import into intact cells was dependent on a hydrophobic region selected from the signal peptide sequences and was verified by their inaccessibility to extracellular proteases and by confocal laser scanning microscopy. When a cell-permeable peptide carried a functional cargo representing the nuclear localization sequence of NF-kappa B p50, it inhibited in a concentration-dependent manner nuclear translocation of NF-kappa B in cultured endothelial and monocytic cells stimulated with lipopolysaccharide or tumor necrosis factor-alpha. Synthetic peptide analogues with deleted hydrophobic cell membrane-permeable motif or with a mutated nuclear localization sequence were inactive. Cell membrane-permeable peptides were not cytotoxic within the concentration range used in these experiments. These results suggest that cell-permeable synthetic peptides carrying a functional cargo can be applied to control signal transduction-dependent subcellular traffic of transcription factors mediating the cellular responses to different agonists. Moreover, this approach can be used to study other intracellular processes involving proteins with functionally distinct domains.
Similar articles
- A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.
Huang TT, Kudo N, Yoshida M, Miyamoto S. Huang TT, et al. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1014-9. doi: 10.1073/pnas.97.3.1014. Proc Natl Acad Sci U S A. 2000. PMID: 10655476 Free PMC article. - Peptide-directed suppression of a pro-inflammatory cytokine response.
Liu XY, Robinson D, Veach RA, Liu D, Timmons S, Collins RD, Hawiger J. Liu XY, et al. J Biol Chem. 2000 Jun 2;275(22):16774-8. doi: 10.1074/jbc.C000083200. J Biol Chem. 2000. PMID: 10751381 - A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease.
Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, Nadler SG. Fujihara SM, et al. J Immunol. 2000 Jul 15;165(2):1004-12. doi: 10.4049/jimmunol.165.2.1004. J Immunol. 2000. PMID: 10878377 - Inhibition of NF-kappa B activation by peptides targeting NF-kappa B essential modulator (nemo) oligomerization.
Agou F, Courtois G, Chiaravalli J, Baleux F, Coïc YM, Traincard F, Israël A, Véron M. Agou F, et al. J Biol Chem. 2004 Dec 24;279(52):54248-57. doi: 10.1074/jbc.M406423200. Epub 2004 Oct 5. J Biol Chem. 2004. PMID: 15466857
Cited by
- Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression.
Tian E, Børset M, Sawyer JR, Brede G, Våtsveen TK, Hov H, Waage A, Barlogie B, Shaughnessy JD Jr, Epstein J, Sundan A. Tian E, et al. Genes Chromosomes Cancer. 2015 Nov;54(11):692-701. doi: 10.1002/gcc.22280. Epub 2015 Jul 29. Genes Chromosomes Cancer. 2015. PMID: 26220195 Free PMC article. - Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation.
Tanaka M, Mroz P, Dai T, Huang L, Morimoto Y, Kinoshita M, Yoshihara Y, Nemoto K, Shinomiya N, Seki S, Hamblin MR. Tanaka M, et al. PLoS One. 2012;7(6):e39823. doi: 10.1371/journal.pone.0039823. Epub 2012 Jun 26. PLoS One. 2012. PMID: 22761911 Free PMC article. - Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.
Davis RL, Das S, Buck DJ, Stevens CW. Davis RL, et al. Neurochem Int. 2013 Mar;62(4):478-85. doi: 10.1016/j.neuint.2013.01.013. Epub 2013 Jan 31. Neurochem Int. 2013. PMID: 23376103 Free PMC article. - Inhibition of IRF5 hyperactivation protects from lupus onset and severity.
Song S, De S, Nelson V, Chopra S, LaPan M, Kampta K, Sun S, He M, Thompson CD, Li D, Shih T, Tan N, Al-Abed Y, Capitle E, Aranow C, Mackay M, Clapp WL, Barnes BJ. Song S, et al. J Clin Invest. 2020 Dec 1;130(12):6700-6717. doi: 10.1172/JCI120288. J Clin Invest. 2020. PMID: 32897883 Free PMC article. Clinical Trial. - NGF controls dendrite development in hippocampal neurons by binding to p75NTR and modulating the cellular targets of Notch.
Salama-Cohen P, Arévalo MA, Meier J, Grantyn R, Rodríguez-Tébar A. Salama-Cohen P, et al. Mol Biol Cell. 2005 Jan;16(1):339-47. doi: 10.1091/mbc.e04-05-0438. Epub 2004 Oct 20. Mol Biol Cell. 2005. PMID: 15496460 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials